You are currently viewing a new version of our website. To view the old version click .
Hematology Reports
  • Hematology Reports is published by MDPI from Volume 14 Issue 1 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.
  • Case Report
  • Open Access

24 September 2010

Amiodarone-Induced Bone Marrow Granulomas: An Unusual Cause of Reversible Pancytopenia

,
and
1
Mayo Medical School, Mayo Cinic, Rochester, MN 55905, USA
2
Department of Laboratory Medicine and Pathology, Mayo Cinic, Rochester, MN 55905, USA
3
Division of Hematology, Department of Internal Medicine, Mayo Cinic, 200 1st St SW, Rochester, MN 55905, USA
*
Author to whom correspondence should be addressed.

Abstract

Bone marrow infiltration by granulomas rarely presents with cytopenias and is usually a result of atypical infections, lymphomas, or sarcoidosis. Drugs are also an important but often overlooked causal agent of bone marrow granulomas. Although rare, amiodarone has been associated with bone marrow granuloma formation. This case report describes a 73-year-old male who presented with pancyto­penia during a preoperative evaluation. Amiodarone therapy was suspected to be the causal agent after diagnostic evaluation and exclusion of other causes. After cessation of amiodarone, the patient’s pancytopenia gradually resolved over a period of several months. Our report illustrates an often overlooked yet important cause of reversible pancytopenia owing to suspected amiodarone-induced bone marrow granuloma formation, and guides clin­icians in an expected timeline for blood count improvement after cessation of this drug.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.